# ARHGAP40

## Overview
ARHGAP40 is a gene that encodes the protein Rho GTPase activating protein 40, which is involved in the regulation of Rho GTPases. These proteins are part of the GTPase family, which play a crucial role in various cellular processes, including cytoskeletal dynamics, cell migration, and cell cycle progression. As a GTPase-activating protein (GAP), Rho GTPase activating protein 40 functions to inactivate Rho GTPases by stimulating their intrinsic GTPase activity, thereby converting them from an active GTP-bound state to an inactive GDP-bound state. This regulatory mechanism is essential for maintaining cellular homeostasis and proper signal transduction. The ARHGAP40 gene and its encoded protein are of particular interest in the context of central nervous system diseases, where they have been implicated in conditions such as autism spectrum disorders and Alzheimer's disease due to their role in neuroinflammation and synaptic changes (Lee2021Microexon; mccormack2013regulation).

## Structure


## Function


## Clinical Significance
ARHGAP40 is implicated in several central nervous system (CNS) diseases due to its role in the regulation of Rho GTPases, which are crucial for various cellular processes. Misregulation or mis-splicing of Rho GTPases and their regulators, including ARHGAP40, has been associated with disorders such as autism spectrum disorders (ASD), intellectual disability, schizophrenia, and Alzheimer's disease (AD) (Lee2021Microexon). In particular, microexon splicing, which affects a significant percentage of microexons in ASD, is a notable factor in these conditions. The Rho GTPase pathway, involving genes like ARHGAP40, is linked to these psychiatric disorders, suggesting that defects in splicing regulatory elements and RNA-binding proteins might contribute to disease pathogenesis (Lee2021Microexon).

Despite its potential significance, ARHGAP40 has not been functionally characterized in detail, and little is known about its specific role or associations with diseases (mccormack2013regulation). This lack of detailed information highlights the need for further research to understand the clinical implications of ARHGAP40 in disease contexts. Current studies suggest its involvement in neuroinflammation and synaptic changes, which are critical in CNS diseases (Lee2021Microexon).


## References


[1. (Lee2021Microexon) Jee‐San Lee, Nathalie Lamarche‐Vane, and Stéphane Richard. Microexon alternative splicing of small <scp>gtpase</scp> regulators: implication in central nervous system diseases. WIREs RNA, June 2021. URL: http://dx.doi.org/10.1002/wrna.1678, doi:10.1002/wrna.1678. This article has 6 citations.](https://doi.org/10.1002/wrna.1678)

2. (mccormack2013regulation) Jessica McCormack. The regulation of cell-cell adhesion by GTPase activating proteins. PhD thesis, Imperial College London, 2013. This article has 2 citations.